Skip to content

The American Society for Preventive Cardiology

JOIN        LOGIN        CONTACT

The American Society for Preventive Cardiology

  • Join ASPC
  • Login
  • Contact Us
aspc-logo-219
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Advocacy Statements
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
      • Navigating Open Enrollment for People Living with CVD
      • U.S. Apheresis Treatment Centers
    • Tools for Clinicians
      • American Journal of Preventive Cardiology
      • ASPC Clinical Practice Statements
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
      • Nonstatin PA Checklist
      • Coverage for Nutrition Services
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
  • Professional Development
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • Cardiometabolic Fellowship
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Advocacy Statements
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
      • Navigating Open Enrollment for People Living with CVD
      • U.S. Apheresis Treatment Centers
    • Tools for Clinicians
      • American Journal of Preventive Cardiology
      • ASPC Clinical Practice Statements
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
      • Nonstatin PA Checklist
      • Coverage for Nutrition Services
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
  • Professional Development
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • Cardiometabolic Fellowship
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
Search
Close

Scientific Statements

Click here to view all of the ASPC Clinical Practice Statements

Continuity of Care and Outpatient Management for Patients with And at High Risk for Cardiovascular Disease during the COVID-19 Pandemic from the American Society for Preventive Cardiology

AHA Statement on FH

Consensus Statement: Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

JOIN ASPC
LOGIN

Contact

The American Society for Preventive Cardiology
450-106 SR 13 N, #140
Jacksonville, FL 32259-3863

Phone: 833-ASK-ASPC
Email: contact@aspconline.org

  • Home
  • About Us
  • Membership
  • News
  • Contact Us
  • DocMatter Login
  • Intervent

Latest News

Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook

Basel, July 07, 2023 — Novartis today announced that the U.S. District Court…

US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease

EAST HANOVER, N.J., July 10, 2023 /PRNewswire/ — Novartis announced today that the US…

LEXICON ANNOUNCES FDA APPROVAL OF INPEFA™ (SOTAGLIFLOZIN) FOR TREATMENT OF HEART FAILURE

The Woodlands, Texas, May 26, 2023 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that…

Connect with us

𝕏

SUBSCRIBE NOW

Get notified with latest updates, press releases, webinars and more!

ASPC MC Subscribe

© 2019 The American Society for Preventive Cardiology. All Rights Reserved. Privacy Policy

Scroll To Top